top of page

The TRanslational Initiative to DE-Risk Therapeutics

New preprint from the Douglas Research Centre team, "Experimental Quality Control Induces Changes in Allen Mouse Brain Connectomes" by Nathan, V et al. Link Here!

Revolutionary
Preclinical
Evaluation.

F3BBVLoaYAEUrB9.jpg

 

The TRanslational Initiative to ​DErisk NeuroTherapeutic (TRIDENT) draws upon research supported by the Government of Canada’s New Frontiers in Research Fund (NFRF).
 

Le TRanslational Initiative to ​DErisk NeuroTherapeutic (TRIDENT) repose sur des recherches financées par le fonds Nouvelles frontières en recherche dugouvernement du Canada.


By offering a transformative approach to preclinical evaluation of neurotherapeutics, TRIDENT will dramatically improve the odds of success of  neurotherapeutics in clinical trials for the benefit of humans across the globe.

One Platform.
3 Integrated Model Systems.

bottom of page